dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs762781471
Current Build 156
Released September 21, 2022
- Organism
- Homo sapiens
- Position
-
chr4:1805654 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- G>A / G>T
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
-
A=0.000008 (2/264690, TOPMED)T=0.000004 (1/250348, GnomAD_exome)A=0.000007 (1/140276, GnomAD) (+ 3 more)
- Clinical Significance
- Not Reported in ClinVar
- Gene : Consequence
- FGFR3 : Missense Variant
- Publications
- 0 citations
- Genomic View
- See rs on genome
ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.
| Population | Group | Sample Size | Ref Allele | Alt Allele |
|---|---|---|---|---|
| Total | Global | 14050 | G=1.00000 | A=0.00000 |
| European | Sub | 9690 | G=1.0000 | A=0.0000 |
| African | Sub | 2898 | G=1.0000 | A=0.0000 |
| African Others | Sub | 114 | G=1.000 | A=0.000 |
| African American | Sub | 2784 | G=1.0000 | A=0.0000 |
| Asian | Sub | 112 | G=1.000 | A=0.000 |
| East Asian | Sub | 86 | G=1.00 | A=0.00 |
| Other Asian | Sub | 26 | G=1.00 | A=0.00 |
| Latin American 1 | Sub | 146 | G=1.000 | A=0.000 |
| Latin American 2 | Sub | 610 | G=1.000 | A=0.000 |
| South Asian | Sub | 98 | G=1.00 | A=0.00 |
| Other | Sub | 496 | G=1.000 | A=0.000 |
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
Download| Study | Population | Group | Sample Size | Ref Allele | Alt Allele |
|---|---|---|---|---|---|
| TopMed | Global | Study-wide | 264690 | G=0.999992 | A=0.000008 |
| gnomAD - Exomes | Global | Study-wide | 250348 | G=0.999996 | T=0.000004 |
| gnomAD - Exomes | European | Sub | 134526 | G=0.999993 | T=0.000007 |
| gnomAD - Exomes | Asian | Sub | 48970 | G=1.00000 | T=0.00000 |
| gnomAD - Exomes | American | Sub | 34550 | G=1.00000 | T=0.00000 |
| gnomAD - Exomes | African | Sub | 16178 | G=1.00000 | T=0.00000 |
| gnomAD - Exomes | Ashkenazi Jewish | Sub | 10016 | G=1.00000 | T=0.00000 |
| gnomAD - Exomes | Other | Sub | 6108 | G=1.0000 | T=0.0000 |
| gnomAD - Genomes | Global | Study-wide | 140276 | G=0.999993 | A=0.000007 |
| gnomAD - Genomes | European | Sub | 75950 | G=1.00000 | A=0.00000 |
| gnomAD - Genomes | African | Sub | 42050 | G=0.99998 | A=0.00002 |
| gnomAD - Genomes | American | Sub | 13666 | G=1.00000 | A=0.00000 |
| gnomAD - Genomes | Ashkenazi Jewish | Sub | 3324 | G=1.0000 | A=0.0000 |
| gnomAD - Genomes | East Asian | Sub | 3132 | G=1.0000 | A=0.0000 |
| gnomAD - Genomes | Other | Sub | 2154 | G=1.0000 | A=0.0000 |
| ExAC | Global | Study-wide | 120088 | G=0.999992 | T=0.000008 |
| ExAC | Europe | Sub | 72336 | G=0.99999 | T=0.00001 |
| ExAC | Asian | Sub | 25096 | G=1.00000 | T=0.00000 |
| ExAC | American | Sub | 11534 | G=1.00000 | T=0.00000 |
| ExAC | African | Sub | 10226 | G=1.00000 | T=0.00000 |
| ExAC | Other | Sub | 896 | G=1.000 | T=0.000 |
| 14KJPN | JAPANESE | Study-wide | 28258 | G=0.99996 | A=0.00004 |
| Allele Frequency Aggregator | Total | Global | 14050 | G=1.00000 | A=0.00000 |
| Allele Frequency Aggregator | European | Sub | 9690 | G=1.0000 | A=0.0000 |
| Allele Frequency Aggregator | African | Sub | 2898 | G=1.0000 | A=0.0000 |
| Allele Frequency Aggregator | Latin American 2 | Sub | 610 | G=1.000 | A=0.000 |
| Allele Frequency Aggregator | Other | Sub | 496 | G=1.000 | A=0.000 |
| Allele Frequency Aggregator | Latin American 1 | Sub | 146 | G=1.000 | A=0.000 |
| Allele Frequency Aggregator | Asian | Sub | 112 | G=1.000 | A=0.000 |
| Allele Frequency Aggregator | South Asian | Sub | 98 | G=1.00 | A=0.00 |
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
| Sequence name | Change |
|---|---|
| GRCh38.p14 chr 4 | NC_000004.12:g.1805654G>A |
| GRCh38.p14 chr 4 | NC_000004.12:g.1805654G>T |
| GRCh37.p13 chr 4 | NC_000004.11:g.1807381G>A |
| GRCh37.p13 chr 4 | NC_000004.11:g.1807381G>T |
| FGFR3 RefSeqGene (LRG_1021) | NG_012632.1:g.17343G>A |
| FGFR3 RefSeqGene (LRG_1021) | NG_012632.1:g.17343G>T |
| Molecule type | Change | Amino acid[Codon] | SO Term |
|---|---|---|---|
| FGFR3 transcript variant 4 | NM_001354809.2:c.1633G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 4 precursor | NP_001341738.1:p.Ala545Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant 4 | NM_001354809.2:c.1633G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 4 precursor | NP_001341738.1:p.Ala545Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant 5 | NM_001354810.2:c.1633G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 5 precursor | NP_001341739.1:p.Ala545Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant 5 | NM_001354810.2:c.1633G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 5 precursor | NP_001341739.1:p.Ala545Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant 1 | NM_000142.5:c.1630G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 1 precursor | NP_000133.1:p.Ala544Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant 1 | NM_000142.5:c.1630G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 1 precursor | NP_000133.1:p.Ala544Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant 2 | NM_022965.4:c.1294G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 2 precursor | NP_075254.1:p.Ala432Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant 2 | NM_022965.4:c.1294G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 2 precursor | NP_075254.1:p.Ala432Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant 3 | NM_001163213.2:c.1636G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 3 precursor | NP_001156685.1:p.Ala546Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant 3 | NM_001163213.2:c.1636G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform 3 precursor | NP_001156685.1:p.Ala546Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant 6 | NR_148971.2:n.2056G>A | N/A | Non Coding Transcript Variant |
| FGFR3 transcript variant 6 | NR_148971.2:n.2056G>T | N/A | Non Coding Transcript Variant |
| FGFR3 transcript variant X1 | XM_006713868.2:c.1642G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X1 | XP_006713931.1:p.Ala548Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X1 | XM_006713868.2:c.1642G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X1 | XP_006713931.1:p.Ala548Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X2 | XM_047449820.1:c.1642G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X1 | XP_047305776.1:p.Ala548Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X2 | XM_047449820.1:c.1642G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X1 | XP_047305776.1:p.Ala548Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X3 | XM_006713870.2:c.1639G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X2 | XP_006713933.1:p.Ala547Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X3 | XM_006713870.2:c.1639G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X2 | XP_006713933.1:p.Ala547Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X4 | XM_006713869.2:c.1642G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X3 | XP_006713932.1:p.Ala548Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X4 | XM_006713869.2:c.1642G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X3 | XP_006713932.1:p.Ala548Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X5 | XM_047449821.1:c.1639G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X4 | XP_047305777.1:p.Ala547Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X5 | XM_047449821.1:c.1639G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X4 | XP_047305777.1:p.Ala547Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X6 | XM_006713871.2:c.1636G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X5 | XP_006713934.1:p.Ala546Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X6 | XM_006713871.2:c.1636G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X5 | XP_006713934.1:p.Ala546Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X7 | XM_011513420.2:c.1636G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X6 | XP_011511722.1:p.Ala546Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X7 | XM_011513420.2:c.1636G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X6 | XP_011511722.1:p.Ala546Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X8 | XM_011513422.2:c.1633G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X7 | XP_011511724.1:p.Ala545Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X8 | XM_011513422.2:c.1633G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X7 | XP_011511724.1:p.Ala545Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X9 | XM_047449822.1:c.1633G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X8 | XP_047305778.1:p.Ala545Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X9 | XM_047449822.1:c.1633G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X8 | XP_047305778.1:p.Ala545Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X10 | XM_006713873.2:c.1630G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X9 | XP_006713936.1:p.Ala544Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X10 | XM_006713873.2:c.1630G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X9 | XP_006713936.1:p.Ala544Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X11 | XM_047449823.1:c.1630G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X9 | XP_047305779.1:p.Ala544Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X11 | XM_047449823.1:c.1630G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X9 | XP_047305779.1:p.Ala544Ser | A (Ala) > S (Ser) | Missense Variant |
| FGFR3 transcript variant X12 | XM_047449824.1:c.1630G>A | A [GCC] > T [ACC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X10 | XP_047305780.1:p.Ala544Thr | A (Ala) > T (Thr) | Missense Variant |
| FGFR3 transcript variant X12 | XM_047449824.1:c.1630G>T | A [GCC] > S [TCC] | Coding Sequence Variant |
| fibroblast growth factor receptor 3 isoform X10 | XP_047305780.1:p.Ala544Ser | A (Ala) > S (Ser) | Missense Variant |
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
| Placement | G= | A | T |
|---|---|---|---|
| GRCh38.p14 chr 4 | NC_000004.12:g.1805654= | NC_000004.12:g.1805654G>A | NC_000004.12:g.1805654G>T |
| GRCh37.p13 chr 4 | NC_000004.11:g.1807381= | NC_000004.11:g.1807381G>A | NC_000004.11:g.1807381G>T |
| FGFR3 RefSeqGene (LRG_1021) | NG_012632.1:g.17343= | NG_012632.1:g.17343G>A | NG_012632.1:g.17343G>T |
| FGFR3 transcript variant 1 | NM_000142.5:c.1630= | NM_000142.5:c.1630G>A | NM_000142.5:c.1630G>T |
| FGFR3 transcript variant 1 | NM_000142.4:c.1630= | NM_000142.4:c.1630G>A | NM_000142.4:c.1630G>T |
| FGFR3 transcript variant 2 | NM_022965.4:c.1294= | NM_022965.4:c.1294G>A | NM_022965.4:c.1294G>T |
| FGFR3 transcript variant 2 | NM_022965.3:c.1294= | NM_022965.3:c.1294G>A | NM_022965.3:c.1294G>T |
| FGFR3 transcript variant 6 | NR_148971.2:n.2056= | NR_148971.2:n.2056G>A | NR_148971.2:n.2056G>T |
| FGFR3 transcript variant 6 | NR_148971.1:n.2037= | NR_148971.1:n.2037G>A | NR_148971.1:n.2037G>T |
| FGFR3 transcript variant 3 | NM_001163213.2:c.1636= | NM_001163213.2:c.1636G>A | NM_001163213.2:c.1636G>T |
| FGFR3 transcript variant 3 | NM_001163213.1:c.1636= | NM_001163213.1:c.1636G>A | NM_001163213.1:c.1636G>T |
| FGFR3 transcript variant 4 | NM_001354809.2:c.1633= | NM_001354809.2:c.1633G>A | NM_001354809.2:c.1633G>T |
| FGFR3 transcript variant 4 | NM_001354809.1:c.1633= | NM_001354809.1:c.1633G>A | NM_001354809.1:c.1633G>T |
| FGFR3 transcript variant 5 | NM_001354810.2:c.1633= | NM_001354810.2:c.1633G>A | NM_001354810.2:c.1633G>T |
| FGFR3 transcript variant 5 | NM_001354810.1:c.1633= | NM_001354810.1:c.1633G>A | NM_001354810.1:c.1633G>T |
| FGFR3 transcript variant X1 | XM_006713868.2:c.1642= | XM_006713868.2:c.1642G>A | XM_006713868.2:c.1642G>T |
| FGFR3 transcript variant X1 | XM_006713868.1:c.1642= | XM_006713868.1:c.1642G>A | XM_006713868.1:c.1642G>T |
| FGFR3 transcript variant X3 | XM_006713870.2:c.1639= | XM_006713870.2:c.1639G>A | XM_006713870.2:c.1639G>T |
| FGFR3 transcript variant X3 | XM_006713870.1:c.1639= | XM_006713870.1:c.1639G>A | XM_006713870.1:c.1639G>T |
| FGFR3 transcript variant X4 | XM_006713869.2:c.1642= | XM_006713869.2:c.1642G>A | XM_006713869.2:c.1642G>T |
| FGFR3 transcript variant X2 | XM_006713869.1:c.1642= | XM_006713869.1:c.1642G>A | XM_006713869.1:c.1642G>T |
| FGFR3 transcript variant X7 | XM_011513420.2:c.1636= | XM_011513420.2:c.1636G>A | XM_011513420.2:c.1636G>T |
| FGFR3 transcript variant X5 | XM_011513420.1:c.1636= | XM_011513420.1:c.1636G>A | XM_011513420.1:c.1636G>T |
| FGFR3 transcript variant X6 | XM_006713871.2:c.1636= | XM_006713871.2:c.1636G>A | XM_006713871.2:c.1636G>T |
| FGFR3 transcript variant X4 | XM_006713871.1:c.1636= | XM_006713871.1:c.1636G>A | XM_006713871.1:c.1636G>T |
| FGFR3 transcript variant X8 | XM_011513422.2:c.1633= | XM_011513422.2:c.1633G>A | XM_011513422.2:c.1633G>T |
| FGFR3 transcript variant X6 | XM_011513422.1:c.1633= | XM_011513422.1:c.1633G>A | XM_011513422.1:c.1633G>T |
| FGFR3 transcript variant X10 | XM_006713873.2:c.1630= | XM_006713873.2:c.1630G>A | XM_006713873.2:c.1630G>T |
| FGFR3 transcript variant X7 | XM_006713873.1:c.1630= | XM_006713873.1:c.1630G>A | XM_006713873.1:c.1630G>T |
| FGFR3 transcript variant X5 | XM_047449821.1:c.1639= | XM_047449821.1:c.1639G>A | XM_047449821.1:c.1639G>T |
| FGFR3 transcript variant X2 | XM_047449820.1:c.1642= | XM_047449820.1:c.1642G>A | XM_047449820.1:c.1642G>T |
| FGFR3 transcript variant X11 | XM_047449823.1:c.1630= | XM_047449823.1:c.1630G>A | XM_047449823.1:c.1630G>T |
| FGFR3 transcript variant X9 | XM_047449822.1:c.1633= | XM_047449822.1:c.1633G>A | XM_047449822.1:c.1633G>T |
| FGFR3 transcript variant X12 | XM_047449824.1:c.1630= | XM_047449824.1:c.1630G>A | XM_047449824.1:c.1630G>T |
| fibroblast growth factor receptor 3 isoform 1 precursor | NP_000133.1:p.Ala544= | NP_000133.1:p.Ala544Thr | NP_000133.1:p.Ala544Ser |
| fibroblast growth factor receptor 3 isoform 2 precursor | NP_075254.1:p.Ala432= | NP_075254.1:p.Ala432Thr | NP_075254.1:p.Ala432Ser |
| fibroblast growth factor receptor 3 isoform 3 precursor | NP_001156685.1:p.Ala546= | NP_001156685.1:p.Ala546Thr | NP_001156685.1:p.Ala546Ser |
| fibroblast growth factor receptor 3 isoform 4 precursor | NP_001341738.1:p.Ala545= | NP_001341738.1:p.Ala545Thr | NP_001341738.1:p.Ala545Ser |
| fibroblast growth factor receptor 3 isoform 5 precursor | NP_001341739.1:p.Ala545= | NP_001341739.1:p.Ala545Thr | NP_001341739.1:p.Ala545Ser |
| fibroblast growth factor receptor 3 isoform X1 | XP_006713931.1:p.Ala548= | XP_006713931.1:p.Ala548Thr | XP_006713931.1:p.Ala548Ser |
| fibroblast growth factor receptor 3 isoform X2 | XP_006713933.1:p.Ala547= | XP_006713933.1:p.Ala547Thr | XP_006713933.1:p.Ala547Ser |
| fibroblast growth factor receptor 3 isoform X3 | XP_006713932.1:p.Ala548= | XP_006713932.1:p.Ala548Thr | XP_006713932.1:p.Ala548Ser |
| fibroblast growth factor receptor 3 isoform X6 | XP_011511722.1:p.Ala546= | XP_011511722.1:p.Ala546Thr | XP_011511722.1:p.Ala546Ser |
| fibroblast growth factor receptor 3 isoform X5 | XP_006713934.1:p.Ala546= | XP_006713934.1:p.Ala546Thr | XP_006713934.1:p.Ala546Ser |
| fibroblast growth factor receptor 3 isoform X7 | XP_011511724.1:p.Ala545= | XP_011511724.1:p.Ala545Thr | XP_011511724.1:p.Ala545Ser |
| fibroblast growth factor receptor 3 isoform X9 | XP_006713936.1:p.Ala544= | XP_006713936.1:p.Ala544Thr | XP_006713936.1:p.Ala544Ser |
| fibroblast growth factor receptor 3 isoform X4 | XP_047305777.1:p.Ala547= | XP_047305777.1:p.Ala547Thr | XP_047305777.1:p.Ala547Ser |
| fibroblast growth factor receptor 3 isoform X1 | XP_047305776.1:p.Ala548= | XP_047305776.1:p.Ala548Thr | XP_047305776.1:p.Ala548Ser |
| fibroblast growth factor receptor 3 isoform X9 | XP_047305779.1:p.Ala544= | XP_047305779.1:p.Ala544Thr | XP_047305779.1:p.Ala544Ser |
| fibroblast growth factor receptor 3 isoform X8 | XP_047305778.1:p.Ala545= | XP_047305778.1:p.Ala545Thr | XP_047305778.1:p.Ala545Ser |
| fibroblast growth factor receptor 3 isoform X10 | XP_047305780.1:p.Ala544= | XP_047305780.1:p.Ala544Thr | XP_047305780.1:p.Ala544Ser |
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
| No | Submitter | Submission ID | Date (Build) |
|---|---|---|---|
| 1 | EVA_EXAC | ss1687389639 | Apr 01, 2015 (144) |
| 2 | GNOMAD | ss2734346742 | Nov 08, 2017 (151) |
| 3 | GNOMAD | ss4089290380 | Apr 26, 2021 (155) |
| 4 | TOPMED | ss4600227973 | Apr 26, 2021 (155) |
| 5 | TOMMO_GENOMICS | ss5697367148 | Oct 13, 2022 (156) |
| 6 | EVA | ss5935695219 | Oct 13, 2022 (156) |
| 7 | ExAC | NC_000004.11 - 1807381 | Oct 12, 2018 (152) |
| 8 | gnomAD - Genomes | NC_000004.12 - 1805654 | Apr 26, 2021 (155) |
| 9 | gnomAD - Exomes | NC_000004.11 - 1807381 | Jul 13, 2019 (153) |
| 10 | 14KJPN | NC_000004.12 - 1805654 | Oct 13, 2022 (156) |
| 11 | TopMed | NC_000004.12 - 1805654 | Apr 26, 2021 (155) |
| 12 | ALFA | NC_000004.12 - 1805654 | Apr 26, 2021 (155) |
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
| Submission IDs | Observation SPDI | Canonical SPDI | Source RSIDs |
|---|---|---|---|
| ss5935695219 | NC_000004.11:1807380:G:A | NC_000004.12:1805653:G:A | |
| 137958370, 31204252, 437605529, 8467738832, ss4089290380, ss4600227973, ss5697367148 | NC_000004.12:1805653:G:A | NC_000004.12:1805653:G:A | (self) |
| 7345773, 3446519, ss1687389639, ss2734346742 | NC_000004.11:1807380:G:T | NC_000004.12:1805653:G:T | (self) |
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
No publications for rs762781471
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.